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Aims:We compare spectral analysis of photoplethysmography (PTG) with insulin resistance measured by the
hyperinsulinemic euglycemic clamp (HEC) technique.
Material andMethod: A total of 100 nondiabetic subjects, 43men and 57 women aged 20–63 years, 30 lean, 42
overweight and 28obesewere enrolled in the study. These patients underwent an examinationwithHEC, and an
examination with the PTG spectral analysis and calculation of the PTG Total Power (PTG-TP). Receiver-operating
characteristic (ROC) curves were constructed to determine the speciﬁcity and sensitivity of PTG-TP in the
assessment of insulin resistance.
Results: There is a moderate correlation between insulin sensitivity (M-value) and PTG-TP (r = − 0.64,
p b 0.0001). The ROC curves showed that the most relevant cutoff to the whole study group was a
PTG-TP N 406.2. This cut-off had a sensitivity = 95.7%, speciﬁcity =84,4% and the area under the ROC curve
(AUC) = 0.929 for identifying insulin resistance. All AUC ROC curve analysis were signiﬁcant (p b 0.0001).
Conclusion: The use of the PTG-TP marker measured from the PTG spectral analysis is a useful tool in screening
and follow up of IR, especially in large-scale studies.© 201 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
7     1. Introduction
The prevalence of diabetes mellitus (DM), which type 2 diabetes
mellitus (T2DM) represents 85–95% of cases of diabetes in adults, has
increased dramatically to pandemic proportions; its global prevalence
was 8.5% of the world population in 2014, 422 million adults, and is
predicted to rise 11.6% by 2025. Due to its high prevalence, chronic
course, morbidity and mortality, T2DM has become one of the most
challenging public health problems in the world. This problem is also
reﬂected in the heavy economic burden placed on the global health
care system (Centers for Disease Control and Prevention, 2014).
A higher prevalence of insulin resistance was found in impaired
glucose tolerance (IGT) and T2DM subjects. Impaired glucose
tolerance is an intermediate stage between normal glucose tolerance
and overt diabetes (Lillioja et al., 1993; Reaven, 1988).
Insulin resistance (IR) has long been recognized as a strong predictor
of T2DM,because it is amajorunderlying factor in theT2DMpathogenesis
(Lillioja et al., 1993; Reaven, 1988). In addition, IR has been identiﬁed as ant, State University of Campinas
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c. This is an open access article underrisk factor formany other diseases, including endothelial dysfunction and
cardiovascular disease (DeFronzo & Ferrannini, 1991; Steinberg, Brechtel,
Johnson, Fineberg, & Baron, 1994). In fact, most of the complications of
T2DMare related tomicro andmacrovascular issues. This relationship can
be explained in part by the effects of IR on the vascular endothelium
(Arcaro, 2002; Hsueh & Quiñones, 2003). Beyond the control of glucose
homeostasis, insulin exerts control on vascular homeostasis. In the
endothelium, insulin simultaneously stimulates the production of the
vasodilator nitric oxide (NO) and the vasoconstrictor endothelin-1 (ET-1)
through signaling pathways. Insulin resistance has a strong impact on
vascular homeostasis, the balance between the production of vasodilator
and vasoconstrictor substances shifts that manifests as impaired
endothelial function and micro-vessel disease (Hsueh & Quiñones,
2003; Steinberg et al., 1994).
The ability tomeasure and diagnose insulin resistance is important
in order to understand the etiology of T2DM, to examine the
epidemiology, and to prevent or delay T2DM and its complications.
Several methods have been employed to assess insulin sensitivity/
resistance both in individuals and in study populations. The gold
standard for assessing insulin sensitivity is the hyperinsulinemic
euglycemic clamp (HEC), which measures the whole body insulin
sensitivity in vivo because it directly measures the capacity of insulin
to promote glucose utilization under steady-state conditions
(DeFronzo, Tobin, & Andres, 1979). However, due to the costs ofthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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and invasive nature of the method, it is not practical or applicable in
large-scale epidemiological studies.
For epidemiologic and clinical studies, surrogate measures of
insulin resistance have been developed based on mathematical
models derived from metabolic blood parameters. These surrogate
measures provide a simple estimate for whole body insulin sensitivity
with excellent results to predict insulin sensitivity comparable to
those of the HEC, and therefore they have been widely used in large
scale investigations (Katz et al., 2000; Matsuda & DeFronzo, 1999;
Matthews et al., 1985; McAuley et al., 2001). Yet, even though these
methods are simpler, less expensive, and less laborious than the HEC
method, they are still problematic when applied in a large number of
subjects because they require at least one blood sampling, and a
laboratory setting for blood analysis and storage. Therefore, the
development of new approaches, which are inexpensive, accurate,
and non-invasive to evaluate insulin resistance and hence T2DM
prevention, have become important in clinical investigations and
large-scale studies.
Photoplethysmography (PTG) is an optical measurement tech-
nique that can be used to detect blood volume changes in the
microvascular bed of tissue (Challoner & Ramsay, 1974). PTG has
widespread clinical application as a clinical physiological monitoring,
vascular assessment and autonomic function (Allen, 2007; Challoner
& Ramsay, 1974). PTG has been intensively investigated in different
clinical settings and studies, including heart rate variability analysis
(Gil et al., 2010), metabolic syndrome (Chang, Hsiu, Yang, Fang, & Tsai,
2016), endothelial dysfunction (Gopaul et al., 2001; Hayward, Kraidly,
Webb, & Collins, 2002) and diabetes (Gandhi & Rao, 2014). A wide
variety of algorithms andmodels derived from PTG analysis have been
proposed to study and understand diseases which autonomic nervous
system and vascular function could be affected, including diabetes and
metabolic disorders (Lewis et al., 2014).
In this study, we compare the spectral analysis of photoplethys-
mography (PTG) with insulin resistance measured by the hyperinsu-
linemic euglycemic clamp (HEC) in nondiabetic subjects, comparing
the photoplethysmography-total power index (PTG-TP), obtained
from spectral analysis, with the M-value of the HEC.
2. Research Design and Methods
2.1. Subjects
The study was approved by the ethics committee of the Faculty of
Medical Sciences – State University of Campinas (UNICAMP), and
adheres to the ethical principles of the Declaration of Helsinki. All
subjects provided written informed consent to participate in the
study, including permission to use their data for research purposes.
This was a cross-sectional study. A total of 100 subjects, 43 men and
57 women aged 20–63 years, were studied. Participants were
recruited by voluntary participation through advertising among the
university community. They were invited to attend a health
assessment following a minimum fasting period of 8 h. The health
assessment included the completion of a detailed medical question-
naire, physical examination, anthropometric measurements, and
blood tests. The inclusion criteria were fasting plasma glucose (FPG)
b7.0 mmol/L and HbA1c b6.5%, featuring nondiabetic individuals,
according to the revised American Diabetes Association criteria
(Chamberlain, Rhinehart, Shaefer, & Neuman, 2016); and good
general health as determined by physical examination and medical
questionnaire. The subjects excluded from the studywere individuals:
1) who had major organ disease involving the heart, lung, kidney or
the nervous system, and other endocrine diseases; 2) taking drugs
known to affect glucose homeostasis; were pregnant; had erratic,
accelerated, or mechanically-controlled irregular heart rhythms; 3)
wore an automatic external deﬁbrillator device; had arterial ﬁbrilla-tion or ﬂutter; 4) had atrioventricular block; had any implanted
electronic device; 5) had dyes recently introduced into the blood-
stream, such as methylene blue, indocyanine green, indigo carmine,
and ﬂuorescein; 6) had signiﬁcant levels of dysfunctional hemoglobin,
such as carboxyhemoglobin or methemoglobin; 7) had any condition
restricting blood ﬂow, such as severe systemic vascular resistance;
and/or 8) worn ﬁngernail polish or false ﬁngernails during the testing.
Any of these factors could affect the accuracy of peripheral oxygen
saturation of arterial hemoglobin (SpO2%) measurement from the
pulse oximeter.
2.2. Experimental Procedures and Analytical Methods
Body mass index (BMI) was calculated based on the ratio between
body mass (in kg) and squared height (in meters). In all of the study
subjects, body composition was evaluated by electrical bioimpedance
with a Biodynamics monitor (Biodynamics Corp., Seattle, WA, USA).
Arterial blood pressure was measured by aneroid sphygmomanom-
eter. Plasma glucose was measured with the glucose oxidase method
using an YSI glucose analyzer (YSI 2300-Stat Plus analyzer; YSI, Yellow
Springs, OH, USA). Glycosylated hemoglobin (HbA1c) was measured
by high performance liquid chromatography method using a HPLC
Variant II (BioRad Inc., Hercules, CA, USA).
2.3. Clamp Study
The hyperinsulinemic euglycemic clamp study, which was carried
out after an overnight (12 to 14 h) fast, consisted of 2 h of euglycemic
insulin infusion at a rate of 40 mU/min per meter squared of body
surface area, and was preceded by a 2-h control period as previously
described (DeFronzo et al., 1979). Intracatheters were inserted into an
antecubital vein for the infusion of insulin and glucose. A second
catheter was inserted retrogradely into a wrist vein, and the handwas
placed in a heated box (50–60 °C) for the sampling of arterialized
blood. The infusion was adjusted according to glucose determinations
made every 5 min on a glucose analyzer (Yellow Springs Instruments,
Yellow Springs, OH). For calculation of insulin sensitivity, the glucose
disposal rate (M-value) (milligrams per kilogram per minute) was
calculated from the infusion rate of exogenous glucose during the
second hour of the insulin clamp period, M-value was normalized per
kg fat-free mass (FFM). M-value b4.8 mg/kgffm ∙min was considered
as a diagnosis of insulin resistance. This cut off was deﬁned by the
lowest quartile of insulin resistance in the background population
(Alberti & Zimmet, 1998; Stern et al., 2005; Vistisen, Colagiuri, &
Borch-Johnsen, 2009).
2.4. Spectral Analysis of Photoplethysmography
The ﬁngertip oximeter of the ES Complex system device (LD
Technology, Miami, Florida, USA) was used to assess photoplethysmo-
graphy (Adami et al., 2012) (Fig. 1). Theﬁngertip oximeter is a simple and
noninvasive optical technique, which is comprised of a pulsatile
physiological waveform or photoplethysmography (PTG) attributed to
cardiac synchronous changes in the artery blood volume with each
heartbeat, and it isused toestimate the skinbloodﬂowusing infrared light
(Allen, 2007). The oximeter was placed on the right index ﬁnger, and it
displays in real time the photoelectrical-plethysmographywaveform, and
the signal processing analysis of the waveform allows to determine
PTG-TP by the ES Complex software (Adami et al., 2012; Gandhi & Rao,
2014). The PTG contour analysis has been described in various studies in
Asia, Europe, and the United States (Allen, 2007; Chang et al., 2016;
Gandhi & Rao, 2014).
In the present study, the PTG contour has been analyzed ﬁrst using
the ﬁrst derivative (FD), and then analyzed using the fast Fourier
transform (FFT) (Fig. 2). The PTG spectral analysis, using Fast Fourier
Transforms (FFT) of the total records of the oximeter wave form
Fig. 2. PTG spectral analysis.A1 = amplitudevery lowfrequencies (VLF),A2 = amplitude low
frequencies (LF), A3 = amplitude high frequencies (HF). S1 = surface very low frequencies
(VLF), S2 = surface low frequencies (LF), S3 = surface high frequencies (HF). W1 = width
very low frequencies (VLF), W2 = width low frequencies (LF), W3 = width high
frequencies (HF).
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3.2 Hz and 4.58 Hz), low (LF) (from 1.47 to 2.56 Hz and peak at 2 Hz)
and very low frequencies (VLF) (from 0 to 1.46 Hz and peak at
1.16 Hz). Each frequency area was measured in milliseconds square
(ms2) (Gandhi & Rao, 2014; Lewis et al., 2014). The harmonic
components are expressed in amplitude (in Volt/second or V.s unit),
width (in Hertz or Hz unit) and surface or power (in square
millisecond or ms2 unit). The PTG total power or PTG-TP is the sum
of the 3 surfaces or powers of VLF, LF and HF.
2.5. Statistical Analysis
The objective of the study was to examine the ability of PTG-TP to
detect insulin resistance (M-value b4.8). Statistical analysis was
performed to correlate M-value and PTG-TP using the Spearman's
coefﬁcient. We compared groups by using Mann–Whitney U test.
Receiver-operating characteristic curves were constructed to deter-
mine the speciﬁcity and sensitivity of PTG-TP in detecting M-value
b4.8 mg/kgffm ∙min. Data are reported as means ±SEM. A p-value
b0.05 was considered statistically signiﬁcant. Based upon the
preliminary study results to have 90% power to detect a signiﬁcant
difference between insulin sensitivity subjects with the above mean
and standard deviation at alpha =0.05. Analyses was performed
using MedCalc software for Windows (version 12.6.1, Ostend, Be).
3. Results
A total of 100 subjects, 30 lean, 42 overweight and 28 obese,
classiﬁed according to BMI, were enrolled in the study. The mean BMI
was 28.1 kg/m2 (range 17.9–50.3). Baseline characteristics of the
study subjects stratiﬁed by insulin resistance were shown in Table 1.
IR as evaluated by HEC was presented in 23% of the subjects, which
had an 4.8 mg/kgffm ∙min. Women were presented at 15.8% of the IR
prevalence, while men were presented 32.6%. The BMI, fat mass and
PTG-TP were signiﬁcantly higher for subjects with IR than those
without IR (Table 1).
Fig. 3 depicts a moderate correlation betweenM-value and PTG-TP
(r = − 0.64, p b 0.0001), which were observed in Table 2 in
comparison with distinct insulin resistance indices.
The ROC analysis showed that the most relevant cutoff to the
whole study group was a PTG-TP N 406.2. This cut-off had a
sensitivity = 95.7%, speciﬁcity =84.4% and AUC = 0.929 for identi-Fig. 1. ES Complex device; Integration of the ES complex softwarewith the ﬁngertip oximeter.fying insulin resistance (Fig. 4). In a separate ROC analysis, the
women's group presented a sensitivity =100.0%, speciﬁcity =85.4%
and AUC = 0.926 (cutoff N405.2); while the men's group was
observed at a sensitivity =92.9%, speciﬁcity =82.8% and AUC =
0.933 (cutoff N406.2). All AUC ROC curve analysis were signiﬁcant
(p b 0.0001).
4. Discussion
Given the rising global burden of diabetes, and its impact on
human health, society, economics, and public policy, the early
diagnosis of this disease has become exceedingly important for its
control and treatment. However, 45.8% of diabetic individuals go
undiagnosed (Beagley, Guariguata, Weil, & Motala, 2014). This high
prevalence of undiagnosed diabetics could be explained, among otherTable 1
Study participant characteristics in the groups with and without insulin resistance.
M-value b 4.8 M-value N 4.8 p-value⁎
Number 23 79 -
Sex (male/female) 13/9 34/44 -
Age (years) 32,0 ± 1.9 33.5 ± 1.0 ns
Fasting plasma glucose (mmol/L) 4.8 ± 0.07 4.7 ± 0.03 ns
Hb1Ac (%) 5.6 ± 0.06 5.3 ± 0.04 0.001
Systolic blood pressure (mmHg) 124.5 ± 4.0 111.9 ± 1.6 0.001
Diastolic blood pressure (mmHg) 83.5 ± 2.7 74.3 ± 1.2 0.0001
Body mass index (kg/m2) 34.5 ± 1.7 26.7 ± 0.5 b0.0001
Fat mass (%) 37.2 ± 1.5 29.3 ± 0.8 b0.0001
PTG-TP (m/s2) 527.29 ± 24.15 327.7 ± 10.7 b0.0001
⁎ p-value indicates comparison between those with (M-vale b4.8) versus without
(M-value N4.8) insulin resistance.
Fig. 3. Simple correlation between M-value (mg/kgffm ∙min) and photoplethysmo-
graphic Index, PTG-TP in 100 nondiabetic subjects. (r = −0.64; p b 0.0001; 95%
conﬁdence interval: −0.743 to −0.507).
Fig. 4. ROC analyses of the utility of Photoplethysmographic Index, PTG-TP, for
diagnosing insulin resistance. (n = 100) (standard error: 0.0247; 95% conﬁdence
interval: 0.860 to 0.971).
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asymptomatic feature of DM leads individuals to perform diagnostic
tests much later, when micro or macrovascular complications, such as
retinopathy, nephropathy, and coronary artery disease, have ap-
peared (Thompson et al., 1996). In order to perform earlier diagnosis
of DM, the World Health Organization has recommended the
development of methods and techniques for screening DM (WHO,
2003). Insulin resistance predicts the development of type 2 diabetes
(Lillioja et al., 1993; Reaven, 1988). The increase of IR and beta cell
dysfunction has been viewed as the trigger for the onset of T2DM
(Ferrannini & Natali, 1991). Thus, an IR diagnosis could enable a
medical intervention and/or changes to an individual's life style to
prevent or delay the onset of T2DM.
Although several methods have been available for making
deﬁnitive measurements for IR, the most accurate are in vivo
assessments, including the intravenous glucose tolerance test with
frequent samples (FSIVGTT) (Pacini & Bergman, 1986) and HEC -
which are used as a reference for correlation and validation of other
methods for IR assessment (George et al., 2011; Katz et al., 2000;
Matsuda & DeFronzo, 1999). These techniques, however, are
complicated, labor intensive, expensive and, in general, not suitable
for large-scale studies or routine clinical work. The oral glucoseTable 2
Indexes to estimate insulin resistance/sensitivity and their correlation with
hyperinsulinemic euglycemic clamp (HEC).
Subjects Correlation with HEC
OGTT derived indexes
Hollenbeck et al. (1984) NGT r = 0.61. p = 0.001
Cederholm & Wibell (1990) NGT, IGT, DM r = 0.62. p b 0.0001
Gutt et al. (2000) NGT, IGT, DM r = 0.63. p b 0.001
Matsuda & DeFronzo (1999) NGT, IGT, DM r = 0.73. p b 0.0001
Belﬁore et al. (2001)) NGT, O, ODM r = 0.96. p b 0.001
Stumvoll et al. (2000) NGT, IGT r = 0.80. p b 0.0005
Mari et al. (2001) IGT, DM, O, L r = 0.73. p b 0.0001
Fasting insulin/glucose
plasma indexes
Homa-IR (Bonora et al., 2000) ND r = −0.75. p b 0.0001
Quicki (Katz et al., 2000) NO, O, DM r = 0.78. p b 2 × 10−12
Photoplethysmography Index
PTG-TP NGT, IGT,O,OW,L r = −0.64. p b 0.0001
OGTT = oral glucose tolerance test, NGT = normal glucose tolerance, IGT = impaired
glucose tolerance, DM = type 2 diabetes, ND = non diabetic, O = obese, L = lean,
OW = overweight, NO = non obese, HOMA-IR = homeostasis model assessment
for insulin resistance, Quicki = quantitative insulin sensitivity check index, PTG-TP =
photoplethysmography total power.tolerance test (OGTT) is another in vivo test, and it is the most often
used to measure IR because it is simple, less expensive, and has a good
correlationwith the HEC (Cederholm&Wibell, 1990; Gutt et al., 2000;
Hollenbeck, Chen, Chen, & Reaven, 1984; Mari, Pacini, Murphy,
Ludvik, & Nolan, 2001; Matsuda & DeFronzo, 1999; Stumvoll et al.,
2000). Surrogate measures of insulin sensitivity have been developed
from OGTT. These indices correlate reasonably well with IR measured
by the HEC (Cederholm & Wibell, 1990; Gutt et al., 2000; Mari et al.,
2001; Matsuda & DeFronzo, 1999; Stumvoll et al., 2000). Besides the
traditional in vivo methods to investigate IR, another index was
developed to measure IR in large-scale studies. The HOMA-IR and
QUICKI are the most used indices, because they are simple and have a
good correlation with the HEC (Bonora et al., 2000; Katz et al., 2000).
Although these methods are the most used in the IR assessment in
epidemiological studies, they required a blood specimen for analysis;
which may represent a limitation in some studies.
Various technologies have been developed and employed as
alternatives to these methods. These technologies have been based
on physiological variables - inputs derived through biosensors;
variable interpretation and correlation through speciﬁc algorithms; and
output assessment/diagnosis (Adami et al., 2012; Lewis et al., 2014). The
PTG is an example of this technology, which has been successfully
employed in the evaluation of endothelial dysfunction (Atkin, Laight, &
Cummings, 2016; Gandhi & Rao, 2014; Kuvin et al., 2003). Given the
relationship between insulin resistance and endothelial dysfunction, the
PTG could be used in the assessment of IR.
In our study, adopting a cutoff M-value b4.8 mg/kgffm ∙min to
detect IR, the overall prevalence of IR was 23% in subjects studied. This
result is similar to the IR prevalence found in non-diabetics who were
shown in the literature to be between 20 to 25% (DeFronzo &
Ferrannini, 1991; Matsuda & DeFronzo, 1999; Reaven, 1988). Women
had higher insulin sensitivity results than men; these results may be
associated with gender differences in abdominal fat distribution, in
which the standard gynoecia distribution and related to factors, such
as higher adiponectinemia, promotes high insulin sensitivity (Deng &
Scherer, 2010). The prevalence of IR in normal weight, overweight
and obese subjects was 1, 8 and 12%, respectively. As an established
relationship between IR and obesity (Ferrannini et al., 1997).
The ROC curve analysis results were very signiﬁcant to evaluate the
PTG-TP algorithm in IR diagnostic performance. The PTG-TP sensitivity
and speciﬁcity overall results (sensitivity 95.7%, speciﬁcity =84.4%;
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speciﬁcity =85.4%; AUCROC = 0,926; men: sensitivity =92.9%, Speciﬁc-
ity =82.8%, AUCROC = 0.933) show better results compared to those
obtained in other studies using consolidated methods and indices for IR
assessment. For instance, Qu, Li, Rentfro, Fisher-Hoch, & McCormick
(2011), using HOMA-IR to assess the IR in 1854 Americans of Mexican
descent had a sensitivity of 64.1% and speciﬁcity of 81.8%, AUCROC =
0.809. In another study, Lee et al. (2006), analyzing different cutoffs in
HOMA and Quick, had a 62.8% sensitivity and 65.7% speciﬁcity with
AUC = 0.672 forHOMA, and sensitivity=61.2% and speciﬁcity=66.8%,
AUCROC = 0.671 for a QUICKI. In a study of obese youth, George et al.
(2011), comparing fasting insulin, HOMA-IR, Quick, and derived indices
from OGTT obtained a AUCROC curve range from 0.888 to 0.946.
Moreover, Maarek et al. (2015), study with 1096 subjects showed the
reliability of spectral analysis of PTG to detect diabetic patients in a large
group (respectively sensitivity and speciﬁcity of 78.5% and 90.2%).
In accordance with the aforementioned studies' data, the sensi-
tivity, speciﬁcity and AUCROC found in PTG-TP IR screening, compared
with the gold standard method, showed the signiﬁcance and
relevance of this new method as a practical screening tool in clinical
practice and also for large-scale studies.
Indeed, our results showed a moderate correlation between HEC
and the PTG-TP algorithm (r = −0.64, p b 0.0001). This correlation
was similar to those found in the other IR studies (Belﬁore, Iannello,
Camuto, Fagone, & Cavaleri, 2001; Cederholm & Wibell, 1990; Gutt et
al., 2000; Hollenbeck et al., 1984; Katz et al., 2000; Mari et al., 2001;
Matsuda & DeFronzo, 1999; Stumvoll et al., 2000) (Table 2).
Our results could be explained in the relationship between the
pathogenesis of insulin resistance, autonomic nervous system (ANS)
and endothelial responses. In addition to the metabolic homeostasis,
insulin plays an important role in haemodynamic homeostasis. At the
cellular level, balance between phosphatidylinositol 3-kinase-
(PI3K)-dependent insulin-signaling pathways that regulate endothe-
lial NO production and mitogen activated protein kinase (MAPK)-de-
pendent insulin-signaling pathways regulating the secretion of the
vasoconstrictor endothelin-1 (ET-1) determines the vascular re-
sponse to insulin. Diminished sensitivity to the vascular actions of
insulin is typically accompanied by reduced PI3K-NO pathway and
heightened MAPK-ET-1 pathway (Natali et al., 1997; Potenza,
Addabbo, & Montagnani, 2009). These changes coupled with the
metabolic abnormalities, that include glucotoxicity, lipotoxicity, and
inﬂammation also lead to endothelial dysfunction. On the other hand,
the hyperinsulinemia, present in IR state, was associated with
increased sympathetic activity and attenuation of sympathetic/vagal
balance; both processes, consequently, may lead to vascular dysfunc-
tion (Arcaro, 2002; Muscelli et al., 1998).
Thus, in IR state, autonomic and endothelial dysfunction, associ-
atedwith the loss of insulin action, lead to changes in the PTG analysis,
which was evaluated by the PTG-TP marker.
Although the PTG waveform is comprised of a pulsatile physiological
waveformattributed to cardiac synchronous changes in the blood volume
with each heartbeat and is superimposed on a slowly varying baseline
with various lower frequency components attributed to respiration,
sympatheticnervous systemactivity, and thermoregulation(Allen,2007);
the fact is that PTG-TP showed high speciﬁcity and sensitivity to detect
insulin resistance in non-diabetic subjects in comparison with the HEC,
independently the degree of IR of this study subjects.
The main clinical interest in IR detection is the prevention of
T2DM, as well as its related diseases. The early diagnosis of IR could
prevent or prolong the onset of T2DM, and it could positively impact
the health of individuals, as well as control public health expenditures
which are strongly impacted by T2DM. Although many methods have
been proposed for screening individuals in the general population, the
methods were always invasive, and required a minimum apparatus to
execute. In this context, the PTG-TP marker, which uses only a pulse
oximeter, has signiﬁcant advantages in comparison with othermethods. These advantages are: ease of use, non-invasive approach,
no complex structure, and is extremely cost effective.
Considering an ROC curve analysis performance, our data suggest
that PTG analysis, in comparison with the HEC gold standard, could be
used alternatively to the classical methods of IR assessment, not to
surrogate these methods, but as an efﬁcient screening method.
Therefore, in conclusion the use of the PTG-TP marker measured
from the PTG spectral analysis is a useful tool in screening and follow
up of IR, especially in large-scale studies.
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